About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Ebola Vaccine Proves to be Safe in an Early Trial

by Dr. Trupti Shirole on March 28, 2015 at 6:51 AM
Font : A-A+

 New Ebola Vaccine Proves to be Safe in an Early Trial

There is no licensed vaccine against Ebola which has killed more than 10,000 people in West Africa out of nearly 25,000 infected cases since the start of 2014, mainly in Liberia, Sierra Leone and Guinea. Researchers are trying to find a safe and effective vaccine against the deadly Ebola virus. Latest reports published in The Lancet claim that a new vaccine dubbed Ad5-EBOV has proven to be safe in an early trial in healthy adults in China. Researchers said, "But while it triggered an antibody response in test subjects, further trials must be held to establish whether the drug actually protects against Ebola."

The paper said that up to now, all tested Ebola virus vaccines have been based on the virus strain from the Zaire outbreak in 1976. But, this new vaccine is the first based on the strain of the Ebola virus behind the west African outbreak. Study authors from a variety of research institutions, public health bodies and the Tianjin CanSino Biotechnology company, said, "The Phase I trial tested the safety of the drug in 120 people in China's Jiangsu province in December and January."

Advertisement

During the study people were given a low or high dose of the test vaccine, or a placebo. The researchers then monitored the study participants over 28 days for any side-effects and an immune response through the activation of so-called T-cell infection-fighting white blood cells. The researchers said, "We witnessed no serious adverse events and antibodies were significantly increased in participants. This showed the drug has some potential, though it was not known whether the immune response lasted beyond 28 days, or whether a booster shot would be needed."

Source: Medindia
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Tropical Disease News

Oral Cholera Vaccine Launched in India by Pharma Giants
Mumbai's TechInvention Lifecare and South Korean Eubiologics team up to introduce oral cholera vaccine in India after successful phase III clinical trial.
Evolving Threat of Dengue Virus in India
Scientists have found that the dengue virus has become more severe in India, highlighting the urgent need for vaccines that target the strains found in the country.
 Watch Out for Acute Kidney Disease as a Complication of Malaria
It is important to consider malarial infection in cases of acute kidney injury in someone with a travel history from endemic areas to improve treatment outcomes.
India's Malaria Vaccine Gets the Green Light for First Time in Ghana
Ghana approves the use of the University of Oxford's malaria vaccine, produced by the Serum Institute of India (SII), becoming the first country to adopt the new vaccine.
 Deadly Dengue Virus Hijacks Mosquito Saliva to Spread Sickness
The dengue virus combines molecules from its RNA with mosquito saliva to foil the human immune system and spread dengue fever and related diseases.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

New Ebola Vaccine Proves to be Safe in an Early Trial Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests